Kendall Capital Management Viatris Inc Transaction History
Kendall Capital Management
- $362 Million
- Q2 2025
A detailed history of Kendall Capital Management transactions in Viatris Inc stock. As of the latest transaction made, Kendall Capital Management holds 180,950 shares of VTRS stock, worth $1.68 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
180,950
Previous 215,510
16.04%
Holding current value
$1.68 Million
Previous $1.88 Million
13.96%
% of portfolio
0.45%
Previous 0.57%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,126Shares Held
958MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.34 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$859 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$690 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$602 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$570 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...